Fig. 2: TAZ promoted the angiogenesis of NSCLC cells and activated EGFR signaling. | Cell Death & Disease

Fig. 2: TAZ promoted the angiogenesis of NSCLC cells and activated EGFR signaling.

From: TAZ sensitizes EGFR wild-type non-small-cell lung cancer to gefitinib by promoting amphiregulin transcription

Fig. 2

a–d HUVEC cells were used to form tubes and transfer the chambers in the presence of conditional media. e Cell lysates from transfected H460 and A549 cells were probed with antibodies for TAZ, EGFR signaling and endothelial markers. GAPDH was used as the loading control. Data were shown as mean ± SD. Each experiment was repeated for at least three times. The scale bar is 200 µm. *: p < 0.05; **: p < 0.01

Back to article page